Infographic: How to market your lung cancer screening program. Download

 

The Growth Channel

The latest innovations in market strategy and share competition

GE wins approval for 3D mammography—DBT installs likely to increase

October 20, 2014

For the past three years, Hologic has dominated the digital breast tomosynthesis market as the only FDA-approved vendor in the United States—leaving hundreds of providers working with GE out in the cold when it comes to 3D mammography.

Last month, GE won approval for its 3D mammography technology, increasing competition for Hologic and for the breast imaging market. With 180 units installed in Europe, Australia, Latin America, Southeast Asia, and the Middle East, GE can hope to rapidly grow its tomosynthesis market share.

Read more »

Virginia Mason offers warranties on joint replacements. Here's what it means.

October 16, 2014

In September, Virginia Mason Medical Center made headlines by announcing that it would soon offer warranties on hip and knee replacements, joining the ranks of a few other early adopters providing similar surgical warranties. While warranty programs represent a novel way to enact and communicate a hospital’s commitment to high-quality care, it is not yet clear how widespread these programs may become among orthopedic providers.

Read on to see Service Line Strategy Advisor’s take on the long-term implications of warranties and the potential role of such programs within joint replacements.

Read more »

A new remote monitoring device to lower your HF readmissions

October 14, 2014

As heart failure (HF) readmission rates continue to pose severe financial burdens, hospital leaders have begun to seek alternative tools, such as remote monitoring, to manage HF populations.

One breakthrough remote monitoring device called CardioMEMS HF System has shown to drastically reduce hospital readmission rates. Below we explore the impact of the rise of remote monitoring and how CardioMEMS will play a role.

Read more »

Outpatient joint replacement finally taking off…sort of

Michael Koppenheffer October 8, 2014

The idea that patients could have a major operation like total hip or knee replacement surgery and leave the hospital the same day would have been unimaginable a generation ago. So it’s no surprise that outpatient joint replacement has captured the imagination of orthopedists, patients, and the general public for more than a decade. According to the public website for one of the pioneers of minimally invasive joint replacement, Richard Berger, MD, who practices at Rush University Medical Center:

“…instead of being in the hospital for four to five days, our patients are in the hospital for four to five hours. Instead of being able to drive in two months, they’re able to drive in a week. Instead of being able to go back to work in three months, they are off work for a week or less.”

Those are powerful claims.

Read more »

NIH says sex matters: Invest in women’s health

October 6, 2014

Research shows sex matters when it comes to medical care. In fact, the NIH recently announced that grant applicants will soon have to report the sex balance of their preclinical studies—ensuring a complete picture of appropriate treatment for both men and women.

Over the past few years an increasing amount of literature has been released indicating that a lack of attention to sex differences in the etiology of certain diseases has resulted in inadequate methodologies and strategies to prevent, diagnose, and treat diseases in women, as compared with men. The NIH’s recent announcement places a spotlight on the need for hospitals and health systems to reconsider standard services and treatment options for women.

Progressive providers have found tailoring services to women is not just good medical practice; it’s also good business practice.

Read more »

What structural heart program leaders can learn from heart failure clinics

October 3, 2014

Structural heart disease (SHD) is a popular topic among cardiovascular service line planners lately, buoyed by evidence that transcatheter valve therapies are meeting longer-term clinical goals.

The didactic sessions at the Transcatheter Cardiovascular Therapeutics (TCT) 2014 conference are also evidence that “structural heart” is rapidly expanding beyond valves to encompass interventional therapies for diseases that span the cardiovascular (CV) spectrum, including heart failure (HF) and atrial fibrillation.

Read more »

The real ROI for telehealth

October 1, 2014

Despite notable reimbursement challenges, there are significant benefits—monetary and otherwise—to investing in telehealth. You might be miscalculating the ROI of your telehealth strategy if you’re only looking at revenue.

Read on to see three value measures you don’t want to leave out.

Read more »

Watchful eyes on Watchman: What you need to know for adoption

September 29, 2014

While TAVR “steals the show” in the structural heart space as evidenced by this year’s Transcatheter Cardiovascular Therapeutics (TCT) conference, physician leaders and strategic planners are eyeing a new, niche opportunity—the Watchman device for atrial fibrillation patients—as a way to integrate and differentiate their services.

Atrial fibrillation (AF) patients have a five times greater risk of stroke, and 90% of stroke-causing clots occur in the left atrial appendage (LAA). Historically, cardiac surgeons have surgically removed the vestigial pouch in severe AF patients to minimize this risk.

Read more »

  • Manage your events
  • View your saved items
  • Manage your subscriptions
  • Update personal information
  • Invite a colleague